White Papers

Our complimentary white papers draw on our primary research findings to provide you information on critical life sciences topics. Please fill out the short form accompanying each white paper in the list below. You will then be directed to links to the downloadable PDFs.

Click the download button below to get access to a complimentary white paper.

If you have questions, call (919) 403-6583.

Latest White Papers

    Patient-Centric Marketing: Using Social and Digital Channels to Cultivate Customer-Focused Strategies 2015

    As the commercial landscape shifts to accommodate more competitors and healthcare stakeholders, pharmaceutical companies turn their focus to better include end users’ perspectives. As patients become more informed and active in making healthcare decisions, pharmaceutical companies benefit from reaching out to these customers directly. Patient-centric marketing strategies are an integral part of commercial mixes that allow companies to better encourage brand loyalty and adherence among their target audiences.

    Should IIT Areas of Interest be Publicly Available? Insights from ExL’s MASS East 2015 2015

    When it comes to disseminating their areas of interest to potential investigators, investigator-initiated trial (IIT) teams walk a fine line between transparency and compliance concerns. Areas of interest are critical for life science companies to evaluate IIT proposals and for investigators to understand what types of studies the company will fund. However, executives debate whether or not the areas of interest should be publicly available on the company’s website. IIT teams that post areas of interest in the public domain promote transparency about research gaps and allow a wider range of researchers to submit proposals. But they also risk giving away competitive intelligence and inviting potential compliance inquiries about off-label promotion. IIT teams can balance these concerns by posting very broad topics online, putting specific areas of interest behind an investigator registration page, and/or by entrusting areas of interest to medical science liaisons.

    Understanding the Importance of Mobile Health for Pharma 2015

    Mobile health offers the life sciences industry far-reaching capabilities to connect with multiple healthcare stakeholders, including physicians, patients and caregivers. Consequently, mobile applications serve a number of purposes: from providing consumer groups with much-needed medical information to encouraging patients to maintain their treatment regimens.  However, as this paper will discuss, ensuring that mobile applications provide long-term value begins with building concrete strategies that consider initiatives’ end goals and target audiences.

    Looking Ahead to 2015: The Life Science Executive Guide From Cutting Edge Information 2015

    What are life science companies focusing on for 2015? We draw from our key research findings over the last year to identify three areas that are crucial to the industry. The first major learnings surround (Big) Data management that accommodates both the traditional definition of Big Data and the importance of a wide range of new data sources that are critical to healthcare. The second set of findings focuses on the need for companies to lead the way in dealing with regulatory and transparency issues. The final set outlines how companies use customer-centric practices and strategies to address a cross-section of pharma topics, including physician needs, access challenges, medical information duties, managed market account manager roles, publications strategies, HEOR spending and payer discussions.